Refine by
Chronic Ischemic Heart Failure Suppliers & Manufacturers
6 companies found
based inCaesarea Industrial Park (N), ISRAEL
V-WAVE was established in Israel in 2009 with a focus on developing percutaneous implantable technologies for patients with chronic heart failure. Technology designed by V-Wave, highlighted by its Ventura Interatrial Shunt System, was designed to ...
based inMoorpark, CALIFORNIA (USA)
Based in Moorpark, California, ForaCare Inc. US is a healthcare technology company dedicated to the design and development of products for chronic disease management. The aim of ForaCare Inc. is to complete the cycle of chronic disease management by ...
based inMelbourne, AUSTRALIA
Mesoblast is using its proprietary mesenchymal lineage cell technology platform to develop and commercialize innovative allogeneic cellular medicines to treat complex inflammatory diseases resistant to conventional standard of care. ...
Mesoblast has a strong and extensive global intellectual property (IP) portfolio with protection extending through to at least 2040 in all major markets. This IP position is expected to provide the Company with substantial commercial advantages as ...
based inSan Francisco, CALIFORNIA (USA)
ViCardia Therapeutics, Inc., a Delaware corporation, founded in 2017, is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapies for treating heart failure (HF) involving ...
ViCardia is entering Phase 2 with GP531, a potent, long-lasting, infusion therapy that treats mitochondrial dysfunction that leads to chronic heart failure and ultimately to acute decompensated heart failure. ...
based inWayne, PENNSYLVANIA (USA)
XyloCor Therapeutics is a biopharmaceutical company focused on the development of novel gene therapy for unmet needs in advanced coronary artery disease. In the United States, coronary artery disease is a leading cause of death and disability. Our ...
based inHaifa, ISRAEL
Launched in 2016, Israel Haifa based Paragate Medical is an innovative device company, aiming to revolutionize the heart failure epidemic management by shifting the weight of chronic disease treatment out of the hospital towards home-based care. Our ...